News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AstraZeneca PLC (AZN) Eyes Biosimilars, No Comment on Celltrion, Inc.


8/1/2013 7:28:04 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

AstraZeneca is looking at ways to leverage its capacity to make biotech drugs within its MedImmune unit, including a possible move into so-called biosimilars, its chief executive said on Thursday.

Pascal Soriot declined to comment, however, on whether he might be interested in acquiring a biosimilars business such as South Korea's Celltrion.

Help employers find you! Check out all the jobs and post your resume.

Read at Bloomberg
Read at Reuters
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES